Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression
Clinical trial NCT01732107 · TERMINATED
Trial details
- NCT number
- NCT01732107
- Sponsor
- Noah Hahn, M.D.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2017-03-06
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.